Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide

Debora Pinna, Pasqua Oreste, Tiziana Coradin, Anna Kajaste-Rudnitski, Silvia Ghezzi, Giorgio Zoppetti, Antonella Rotola, Rafaela Argnani, Guido Poli, Roberto Manservigi, Elisa Vicenzi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Herpes simplex virus type 1 (HSV-1) and HSV-2 are neurotropic viruses and common human pathogens causing major public health problems such as genital herpes, a sexually transmitted disease also correlated with increased transmission and replication of human immunodeficiency virus type 1 (HIV-2). Therefore, compounds capable of blocking HIV-1, HSV-1, and HSV-2 transmission represent candidate microbicides with a potential added value over that of molecules acting selectively against either infection. We report here that sulfated derivatives of the Escherichia coli K5 polysaccharide, structurally highly similar to heparin and previously shown to inhibit HIV-1 entry and replication in vitro, also exert suppressive activities against both HSV-1 and HSV-2 infections. In particular, the N,O-sulfated [K5-N,OS(H)] and O-sulfated epimerized [Epi-K5-OS(H)] forms inhibited the infection of Vero cells by HSV-1 and -2, with 50% inhibitory concentrations (IC50) between 3 ± 0.05 and 48 ± 27 nM, and were not toxic to the cells at concentrations as high as 5 μM;. These compounds impaired the early steps of HSV-1 and HSV-2 virion attachment and entry into host cells and reduced the cell-to-cell spread of HSV-2. Since K5-N,OS(H) and Epi-K5-OS(H) also inhibit HIV-1 infection, they may represent valid candidates for development as topical microbicides preventing sexual transmission of HIV-1, HSV-1, and HSV-2.

Original languageEnglish
Pages (from-to)3078-3084
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume52
Issue number9
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Human Herpesvirus 2
Human Herpesvirus 1
Escherichia coli
HIV-1
Infection
Inhibitory Concentration 50
Herpes Genitalis
HIV-2
Vero Cells
Local Anti-Infective Agents
Poisons
Sexually Transmitted Diseases
Anti-Infective Agents
In Vitro Techniques
capsular polysaccharide K5
Virion
HIV Infections
Heparin
Public Health
Viruses

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide. / Pinna, Debora; Oreste, Pasqua; Coradin, Tiziana; Kajaste-Rudnitski, Anna; Ghezzi, Silvia; Zoppetti, Giorgio; Rotola, Antonella; Argnani, Rafaela; Poli, Guido; Manservigi, Roberto; Vicenzi, Elisa.

In: Antimicrobial Agents and Chemotherapy, Vol. 52, No. 9, 09.2008, p. 3078-3084.

Research output: Contribution to journalArticle

Pinna, Debora ; Oreste, Pasqua ; Coradin, Tiziana ; Kajaste-Rudnitski, Anna ; Ghezzi, Silvia ; Zoppetti, Giorgio ; Rotola, Antonella ; Argnani, Rafaela ; Poli, Guido ; Manservigi, Roberto ; Vicenzi, Elisa. / Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide. In: Antimicrobial Agents and Chemotherapy. 2008 ; Vol. 52, No. 9. pp. 3078-3084.
@article{cd09b5e3b1084d72bf8eb609e2cd147e,
title = "Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide",
abstract = "Herpes simplex virus type 1 (HSV-1) and HSV-2 are neurotropic viruses and common human pathogens causing major public health problems such as genital herpes, a sexually transmitted disease also correlated with increased transmission and replication of human immunodeficiency virus type 1 (HIV-2). Therefore, compounds capable of blocking HIV-1, HSV-1, and HSV-2 transmission represent candidate microbicides with a potential added value over that of molecules acting selectively against either infection. We report here that sulfated derivatives of the Escherichia coli K5 polysaccharide, structurally highly similar to heparin and previously shown to inhibit HIV-1 entry and replication in vitro, also exert suppressive activities against both HSV-1 and HSV-2 infections. In particular, the N,O-sulfated [K5-N,OS(H)] and O-sulfated epimerized [Epi-K5-OS(H)] forms inhibited the infection of Vero cells by HSV-1 and -2, with 50{\%} inhibitory concentrations (IC50) between 3 ± 0.05 and 48 ± 27 nM, and were not toxic to the cells at concentrations as high as 5 μM;. These compounds impaired the early steps of HSV-1 and HSV-2 virion attachment and entry into host cells and reduced the cell-to-cell spread of HSV-2. Since K5-N,OS(H) and Epi-K5-OS(H) also inhibit HIV-1 infection, they may represent valid candidates for development as topical microbicides preventing sexual transmission of HIV-1, HSV-1, and HSV-2.",
author = "Debora Pinna and Pasqua Oreste and Tiziana Coradin and Anna Kajaste-Rudnitski and Silvia Ghezzi and Giorgio Zoppetti and Antonella Rotola and Rafaela Argnani and Guido Poli and Roberto Manservigi and Elisa Vicenzi",
year = "2008",
month = "9",
doi = "10.1128/AAC.00359-08",
language = "English",
volume = "52",
pages = "3078--3084",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide

AU - Pinna, Debora

AU - Oreste, Pasqua

AU - Coradin, Tiziana

AU - Kajaste-Rudnitski, Anna

AU - Ghezzi, Silvia

AU - Zoppetti, Giorgio

AU - Rotola, Antonella

AU - Argnani, Rafaela

AU - Poli, Guido

AU - Manservigi, Roberto

AU - Vicenzi, Elisa

PY - 2008/9

Y1 - 2008/9

N2 - Herpes simplex virus type 1 (HSV-1) and HSV-2 are neurotropic viruses and common human pathogens causing major public health problems such as genital herpes, a sexually transmitted disease also correlated with increased transmission and replication of human immunodeficiency virus type 1 (HIV-2). Therefore, compounds capable of blocking HIV-1, HSV-1, and HSV-2 transmission represent candidate microbicides with a potential added value over that of molecules acting selectively against either infection. We report here that sulfated derivatives of the Escherichia coli K5 polysaccharide, structurally highly similar to heparin and previously shown to inhibit HIV-1 entry and replication in vitro, also exert suppressive activities against both HSV-1 and HSV-2 infections. In particular, the N,O-sulfated [K5-N,OS(H)] and O-sulfated epimerized [Epi-K5-OS(H)] forms inhibited the infection of Vero cells by HSV-1 and -2, with 50% inhibitory concentrations (IC50) between 3 ± 0.05 and 48 ± 27 nM, and were not toxic to the cells at concentrations as high as 5 μM;. These compounds impaired the early steps of HSV-1 and HSV-2 virion attachment and entry into host cells and reduced the cell-to-cell spread of HSV-2. Since K5-N,OS(H) and Epi-K5-OS(H) also inhibit HIV-1 infection, they may represent valid candidates for development as topical microbicides preventing sexual transmission of HIV-1, HSV-1, and HSV-2.

AB - Herpes simplex virus type 1 (HSV-1) and HSV-2 are neurotropic viruses and common human pathogens causing major public health problems such as genital herpes, a sexually transmitted disease also correlated with increased transmission and replication of human immunodeficiency virus type 1 (HIV-2). Therefore, compounds capable of blocking HIV-1, HSV-1, and HSV-2 transmission represent candidate microbicides with a potential added value over that of molecules acting selectively against either infection. We report here that sulfated derivatives of the Escherichia coli K5 polysaccharide, structurally highly similar to heparin and previously shown to inhibit HIV-1 entry and replication in vitro, also exert suppressive activities against both HSV-1 and HSV-2 infections. In particular, the N,O-sulfated [K5-N,OS(H)] and O-sulfated epimerized [Epi-K5-OS(H)] forms inhibited the infection of Vero cells by HSV-1 and -2, with 50% inhibitory concentrations (IC50) between 3 ± 0.05 and 48 ± 27 nM, and were not toxic to the cells at concentrations as high as 5 μM;. These compounds impaired the early steps of HSV-1 and HSV-2 virion attachment and entry into host cells and reduced the cell-to-cell spread of HSV-2. Since K5-N,OS(H) and Epi-K5-OS(H) also inhibit HIV-1 infection, they may represent valid candidates for development as topical microbicides preventing sexual transmission of HIV-1, HSV-1, and HSV-2.

UR - http://www.scopus.com/inward/record.url?scp=50949128548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949128548&partnerID=8YFLogxK

U2 - 10.1128/AAC.00359-08

DO - 10.1128/AAC.00359-08

M3 - Article

C2 - 18573926

AN - SCOPUS:50949128548

VL - 52

SP - 3078

EP - 3084

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -